ReviewJournal of cardiac failure2022
Physiology and Clinical Utility of HeartMate Pump Parameters.
Review in Journal of cardiac failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Hematologic complications and design challenges in cardiovascular devices.Communications engineering · 2026Review
- [Left ventricular assist devices in emergency medicine : Case-based analysis for emergency medical services and emergency departments].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026Article
- Abrupt flow decline as the initial indicator of early HeartMate 3 pump thrombosis.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026Article
- Comparison of Intraoperative Doppler Flow Measurements and Algorithmic Flow Estimations in Patients Undergoing Durable Left Ventricular Assist Device Implantation.Artificial organs · 2026Article
- The impact of position changes of the inflow cannula in LVAD patients.Turk gogus kalp damar cerrahisi dergisi · 2026Article
- Management of Dialysis for Patients Receiving Mechanical Circulatory Support.Journal of the American Society of Nephrology : JASN · 2026Review
- Corheart 6 ultracompact magnetically levitated left ventricular assist device in an obese patient with heart failure.ESC heart failure · 2026Article
- Cardiac Rehabilitation After Left Ventricular Assist Device Implantation: A Narrative Review.Journal of clinical medicine · 2026Review
- Non-invasive analysis of pump parameter responses to orthostatic transitions in patients with fully magnetically levitated left ventricular assist devices.European heart journal. Digital health · 2026Article
- No Pulse, No Panic! Navigating Cardiac Arrest in LVAD-Supported Patients.Critical care clinics · 2026Review
- Single-Center Experience with the HeartMate 3 Assist Device in Pediatric Patients with Cardiomyopathy.Medicina (Kaunas, Lithuania) · 2025Article
- Cardiovascular Physiology During Mechanical Circulatory Support: Implications for Management and Monitoring.Journal of clinical medicine · 2025Review
- In Vitro Comparison of Device-Induced Hemolysis, Platelet Defects, and von Willebrand Factor Degradation Between the HeartMate 2 and HeartMate 3 Pumps.Artificial organs · 2025Article
- Accuracy of the HeartMate 3 Left Ventricular Assist Device Flow Estimation.Scientific reports · 2025Article
- Understanding the role of vascular stretch on modulation of VWF and ANGPT-2 in continuous flow left ventricular assist device (CF-VAD) patients.Lab on a chip · 2025Article
- Early-stage Development of the CoRISMA Mechanical Circulatory Support (CMCS) System for Heart Failure Therapy.Cardiovascular engineering and technology · 2024Article
- Successful management of HeartMate 3 in a patient with arrhythmogenic right ventricular cardiomyopathy.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2024Article
- Outcomes of HeartMate 3 in pediatric patients with end-stage heart failure: a single-center preliminary experience from Turkey.Frontiers in cardiovascular medicine · 2024Article
- Aortic valve disorders and left ventricular assist devices.Frontiers in cardiovascular medicine · 2023Review
- A Holistic View of Advanced Heart Failure.Life (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump intended for durable support being actively manufactured and implanted for adults in the United States. The changes in preload and afterload that accompany common clinical scenarios experienced by patients with an LVAD will cause specific changes to the LVAD pump parameters, namely, the pump power, pulsatility index, and flow. Appropriate care of this unique, and growing, population requires a full understanding of these variables as well as the underlying physiologic principles governing their derivation. The aim of this review is to focus on the updated functionality of the HeartMate 3, specifically in comparison to the HeartMate II, as well as the application of pump parameter interpretation to common clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.